PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs.

Int J Mol Sci · 2017 · PMC5666793 · PMID 28991194

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Thus, further studies on the expression level and location of PARP1 in numerous cancers to assist to find more eligibilities of PARP1 inhibitors may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.